Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
N/A
Psoriasis is a chronic inflammatory skin condition that is characterized by...
Status
Active Not Recruiting
Location
Duplicate_Kaplan Medical Center /ID# 226569
Start Date
2021-04-26
Trial ID
NCT04780516
A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants
PHASE1
This study will assess the pharmacokinetics, relative bioavailability, immu...
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
PHASE3
The purpose of this study is to evaluate the safety and efficacy of risanki...